Literature DB >> 16036767

Direct dosing of preweaning rodents in toxicity testing and research: deliberations of an ILSI RSI Expert Working Group.

Virginia C Moser1, Isabel Walls, Tracey Zoetis.   

Abstract

Laboratory animal studies designed to assess the effects of exposure of a test substance during postnatal development are commonly utilized in basic research and to evaluate potential hazard to children for chemical and pharmaceutical regulation. Direct dosing, defined here as the administration of a test substance directly to a preweaning mammal, has been identified as a useful tool that can be used in the conduct of such studies for regulatory purposes. The International Life Sciences Institute Risk Science Institute (ILSI RSI) convened an Expert Working Group to develop guidance on the design and implementation of direct dosing regulatory studies on preweaning mammals, which was published as an ILSI monograph in 2003 (Zoetis and Walls, Principles and Practices for Direct Dosing of Pre-Weaning Mammals in Toxicity Testing and Research, Washington, DC: ILSI Press, 2003). A summary of the Working Group conclusions regarding direct dosing studies with laboratory rodents are presented here, although the ILSI monograph also includes rabbits, canines, swine and nonhuman primates. Issues to be considered when designing the protocol include selection of the test species, the route of administration, dose levels, and the timing of dosing. Knowledge of the maturational status of the test species and information on critical windows of development are important in creating a valid study design. Most common routes of administration (e.g., oral, inhalation, injection) are possible with typical laboratory species; however, adjustments may be necessary due to practical considerations. Information on the pharmacokinetic profile in young animals versus adults and in the test species versus humans is very useful for determining dosing parameters. The conduct of the study and the interpretation of the data will be improved by an understanding of confounding factors as well as statistical and biological issues specific for postnatal studies. Ultimately, the success of the study will depend upon careful preparation, including thorough training of the technical staff.

Entities:  

Mesh:

Year:  2005        PMID: 16036767     DOI: 10.1080/10915810590936355

Source DB:  PubMed          Journal:  Int J Toxicol        ISSN: 1091-5818            Impact factor:   2.032


  5 in total

1.  Administration of substances to laboratory animals: routes of administration and factors to consider.

Authors:  Patricia V Turner; Thea Brabb; Cynthia Pekow; Mary Ann Vasbinder
Journal:  J Am Assoc Lab Anim Sci       Date:  2011-09       Impact factor: 1.232

Review 2.  Is decabromodiphenyl ether (BDE-209) a developmental neurotoxicant?

Authors:  Lucio G Costa; Gennaro Giordano
Journal:  Neurotoxicology       Date:  2010-12-21       Impact factor: 4.294

3.  Neurotoxicity of PBDEs on the developing nervous system.

Authors:  Marek Banasik; Dominika Suchecka
Journal:  Environ Health Perspect       Date:  2011-08       Impact factor: 9.031

4.  Response to Juberg et al.

Authors:  Axel Mie; Christina Rudén; Philippe Grandjean
Journal:  Environ Health       Date:  2019-04-03       Impact factor: 5.984

Review 5.  A retrospective performance assessment of the developmental neurotoxicity study in support of OECD test guideline 426.

Authors:  Susan L Makris; Kathleen Raffaele; Sandra Allen; Wayne J Bowers; Ulla Hass; Enrico Alleva; Gemma Calamandrei; Larry Sheets; Patric Amcoff; Nathalie Delrue; Kevin M Crofton
Journal:  Environ Health Perspect       Date:  2008-08-12       Impact factor: 9.031

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.